These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24410805)

  • 1. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.
    Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I
    Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.
    Burel-Vandenbos F; Benchetrit M; Miquel C; Fontaine D; Auvergne R; Lebrun-Frenay C; Cardot-Leccia N; Michiels JF; Paquis-Flucklinger V; Virolle T
    J Neurooncol; 2011 Apr; 102(2):171-8. PubMed ID: 20652725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
    Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
    J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular classification of diffuse gliomas.
    Jakovlevs A; Vanags A; Gardovskis J; Strumfa I
    Pol J Pathol; 2019; 70(4):246-258. PubMed ID: 32146793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas.
    Suzuki A; Nobusawa S; Natsume A; Suzuki H; Kim YH; Yokoo H; Nagaishi M; Ikota H; Nakazawa T; Wakabayashi T; Ohgaki H; Nakazato Y
    J Neurooncol; 2014 Nov; 120(2):283-91. PubMed ID: 25085214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells.
    Kupp R; Shtayer L; Tien AC; Szeto E; Sanai N; Rowitch DH; Mehta S
    Cell Rep; 2016 Sep; 16(11):2838-2845. PubMed ID: 27626655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.
    Higgins RJ; Dickinson PJ; LeCouteur RA; Bollen AW; Wang H; Wang H; Corely LJ; Moore LM; Zang W; Fuller GN
    J Neurooncol; 2010 May; 98(1):49-55. PubMed ID: 19967449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinicopathologic characteristics of the molecular subtypes in malignant glioma: a multi-institutional analysis of 941 cases.
    Lin N; Yan W; Gao K; Wang Y; Zhang J; You Y
    PLoS One; 2014; 9(4):e94871. PubMed ID: 24755548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
    Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
    J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.
    Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A
    Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.
    Azar S; Leventoux N; Ripoll C; Rigau V; Gozé C; Lorcy F; Bauchet L; Duffau H; Guichet PO; Rothhut B; Hugnot JP
    Glia; 2018 Feb; 66(2):239-255. PubMed ID: 29027701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular subtypes of glioblastoma are relevant to lower grade glioma.
    Guan X; Vengoechea J; Zheng S; Sloan AE; Chen Y; Brat DJ; O'Neill BP; de Groot J; Yust-Katz S; Yung WK; Cohen ML; Aldape KD; Rosenfeld S; Verhaak RG; Barnholtz-Sloan JS
    PLoS One; 2014; 9(3):e91216. PubMed ID: 24614622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of IDH1 in gliomas: a tissue microarray-based approach.
    Sipayya V; Sharma I; Sharma KC; Singh A
    J Cancer Res Ther; 2012; 8(4):598-601. PubMed ID: 23361281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simplified approach for the molecular classification of glioblastomas.
    Le Mercier M; Hastir D; Moles Lopez X; De Nève N; Maris C; Trepant AL; Rorive S; Decaestecker C; Salmon I
    PLoS One; 2012; 7(9):e45475. PubMed ID: 23029035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Prognosis of High-Grade gliomas in the View of New Immunohistochemistry Markers and 2016 WHO Classification.
    Dolen D; Ahmadov T; Dolas I; Unal TC; Aydoseli A; Ozturk M; Sabanci PA; Aras Y; Bilgic MB; Sencer A
    Turk Neurosurg; 2022; 32(3):500-507. PubMed ID: 35615769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between deregulated expression of PER2 gene and degree of glioma malignancy.
    Wang F; Luo Y; Li C; Chen L
    Tumori; 2014; 100(6):e266-72. PubMed ID: 25688509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
    Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas.
    Dénes A; Bontell TO; Barchéus H; Vega SF; Carén H; Lindskog C; Jakola AS; Smits A
    PLoS One; 2023; 18(5):e0285732. PubMed ID: 37192181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental validation of 5 in-silico predicted glioma biomarkers.
    Towner RA; Jensen RL; Vaillant B; Colman H; Saunders D; Giles CB; Wren JD
    Neuro Oncol; 2013 Dec; 15(12):1625-34. PubMed ID: 24158112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas.
    Li JY; Wang H; May S; Song X; Fueyo J; Fuller GN; Wang H
    J Neurooncol; 2008 May; 88(1):11-7. PubMed ID: 18246408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.